Based on these findings, a multistep tumorigenesis model was proposed for AITL.32 In that model, TET2 and DNMT3A mutations occurred as initial events, and RHOA and IDH2 mutations were acquired later in AITL development. The gene discussed is TET2; the disease is angioimmunoblastic T-cell lymphoma.